secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001213900-25-099755
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BiomX shareholders approve reverse stock split authorization and elect Class II directors
--------------------------------------------------------------------------------

- Elected Susan Blum, Dr. Jesse Goodman, and Gregory Merril as Class II directors until 2028.
- Approved board authority to reverse split common stock at a ratio between 1-for-5 and 1-for-20 (13.6M votes for, 383.7K against).
- Ratified Kesselman & Kesselman (PwC member) as independent auditor for fiscal 2025 with 14.05M votes for.
- Adjournment proposal not called due to sufficient votes on other proposals.
- All three proposals passed; broker non-votes were zero on director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/0001213900-25-099755-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/ea0261608-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-099755

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer